1. Home
  2. SVA vs NCZ Comparison

SVA vs NCZ Comparison

Compare SVA & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVA
  • NCZ
  • Stock Information
  • Founded
  • SVA N/A
  • NCZ 2003
  • Country
  • SVA
  • NCZ United States
  • Employees
  • SVA 3261
  • NCZ N/A
  • Industry
  • SVA
  • NCZ Finance Companies
  • Sector
  • SVA
  • NCZ Finance
  • Exchange
  • SVA NYSE
  • NCZ Nasdaq
  • Market Cap
  • SVA N/A
  • NCZ 240.5M
  • IPO Year
  • SVA N/A
  • NCZ N/A
  • Fundamental
  • Price
  • SVA $6.47
  • NCZ $3.17
  • Analyst Decision
  • SVA
  • NCZ
  • Analyst Count
  • SVA 0
  • NCZ 0
  • Target Price
  • SVA N/A
  • NCZ N/A
  • AVG Volume (30 Days)
  • SVA N/A
  • NCZ 533.0K
  • Earning Date
  • SVA N/A
  • NCZ 01-01-0001
  • Dividend Yield
  • SVA N/A
  • NCZ 12.16%
  • EPS Growth
  • SVA N/A
  • NCZ N/A
  • EPS
  • SVA N/A
  • NCZ N/A
  • Revenue
  • SVA N/A
  • NCZ N/A
  • Revenue This Year
  • SVA N/A
  • NCZ N/A
  • Revenue Next Year
  • SVA N/A
  • NCZ N/A
  • P/E Ratio
  • SVA N/A
  • NCZ N/A
  • Revenue Growth
  • SVA N/A
  • NCZ N/A
  • 52 Week Low
  • SVA N/A
  • NCZ $2.50
  • 52 Week High
  • SVA N/A
  • NCZ $3.15
  • Technical
  • Relative Strength Index (RSI)
  • SVA N/A
  • NCZ 58.66
  • Support Level
  • SVA N/A
  • NCZ $3.14
  • Resistance Level
  • SVA N/A
  • NCZ $3.22
  • Average True Range (ATR)
  • SVA 0.00
  • NCZ 0.05
  • MACD
  • SVA 0.00
  • NCZ -0.00
  • Stochastic Oscillator
  • SVA 0.00
  • NCZ 59.37

About SVA SINOVAC BIOTECH LTD

Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.

About NCZ Virtus Convertible & Income Fund II of Beneficial Interest

Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas and consumable fuels and others.

Share on Social Networks: